{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:50:25Z","timestamp":1794775825573,"version":"4.9.1"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Chronic hypercortisolemia due to Cushing\u2019s disease (CD) results in abnormal adipose tissue (AT) distribution. Whole\u2010body magnetic resonance imaging (MRI) was used to examine lean and AT distribution in female patients with CD to further understand the role of glucocorticoid excess in the development of abnormal AT distribution and obesity.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Cross\u2010sectional and case\u2013control study.<\/jats:p><jats:p><jats:bold>Patients\u2002<\/jats:bold> Fifteen women with CD and 12 healthy controls.<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Mass of skeletal muscle (SM) and AT in the visceral (VAT), subcutaneous (SAT), and intermuscular (IMAT) compartments from whole\u2010body MRI and serum levels of insulin, glucose, and leptin were measured.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> CD patients had leptin values that correlated to total AT (TAT) and SAT (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705) but not to VAT. CD patients had higher VAT\/TAT ratios (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701) and lower SAT\/TAT ratios (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b705) compared to controls. TAT, VAT, and trunk SAT (TrSAT) were greater in CD patients (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701). SM was less in CD (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) but IMAT was not different.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> TAT, VAT, trSAT, and the proportion of AT in the visceral depot were greater in CD although the proportion in the subcutaneous depot was less. SM was less but IMAT was not different. These findings have implications for understanding the role of cortisol in the abnormal AT distribution and metabolic risk seen in patients exposed to chronic excess glucocorticoids.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2010.03829.x","type":"journal-article","created":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T21:55:12Z","timestamp":1276120512000},"page":"469-475","source":"Crossref","is-referenced-by-count":66,"title":["MRI assessment of lean and adipose tissue distribution in female patients with Cushing\u2019s disease"],"prefix":"10.1111","volume":"73","author":[{"given":"Eliza B.","family":"Geer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dympna","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Punyanitya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C.","family":"Looker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalmon D.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela U.","family":"Freda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.170.2.2911678"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-6-1122"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1985.tb00182.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-5-1215"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02488.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.11.5301"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03343737"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.9.2791"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.5.633"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801982"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/71.4.885"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803474"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj111"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.4.903"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2780"},{"key":"e_1_2_8_17_2","volume-title":"International Commission on radiological protection, no. 23","author":"Snyder W.S.","year":"1975"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.12.2191"},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1210\/jcem.82.5.3928","article-title":"Dexamethasone increases leptin expression in humans in vivo","volume":"82","author":"Papaspyrou\u2010Rao S.","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0803"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.600"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2003.01987.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979884"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1440021"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.3991"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2006.31"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11222-8"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1297"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490561"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0766"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2010.03829.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2010.03829.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:19:25Z","timestamp":1698758365000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2010.03829.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1365-2265.2010.03829.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03829.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}